Financing Innovation: How Biotechs can fund Drug Development in Creative Ways

Developing new medicines is risky and costly. Recent public market volatility has led the $XBI (ETF that tracks the performance of the S&P® Biotechnology Index) to fall 60% from its 2021 high to the 2022 trough. In this light, biotech companies need to be creative in obtaining financing to support the development of needed medicines. In this session, Alok Tayi, founder of VIBE Bio DAO, will discuss innovative ways of capitalizing on programs & companies such that the organization has the resources required to help patients with novel medicines.

Lab to Cloud Workflows: How to Meet Today’s Data Demands for Availability, Accessibility, and Security

Gathering insight from the massive amount of data produced during the R&D lifecycle of any therapeutic agent research is challenging. The pandemic has highlighted the need to improve our capability to plan, execute and analyze research in a remote environment. Nate McBride, VP of IT at Affinivax, will discuss how the “lab-in-the-cloud” approach can help accelerate research in a collaborative and secure environment.

Third Rock Ventures Customer Story: Effectively Launching Biotechs with a Scalable Data Infrastructure

Learn how life sciences venture capital firm, Third Rock Ventures, implements a tech stack founded on Egnyte that provides support for the data needs of the modern high-growth, data-intensive biotechs throughout their growth journey.
 

Exciting new product announcements from the Egnyte for Life Sciences Team

Over 700 Life Science organizations are able to extract value from Egnyte's platform for Life Science. In continuing our commitment to the LS industry, Ronen Vengosh shares Egnyte's product direction, including products released over the past year and our latest module for biotechs, eTMF.

IDC Analyst Nimita Limaye, Ph.D. on How Data-centricity and Patient-centricity are Transforming Life Sciences

Join Dr. Nimita Limaye, Research VP, Life Sciences R&D Strategy and Technology at IDC, as she reviews the top technology trends for 2022, including patient centricity, digital transformation, and AI.

Egnyte CEO Vineet Jain’s Welcome Remarks

The life science industry is discovering new paths to extract business value as they adopt the cloud. In his opening remarks, Vineet Jain recaps the past year and what is on the horizon for Egnyte as it continues to deliver value to the life science industry.

Welcome Keynote

Join Rajesh Ram, Co-Founder and Chief Experience Officer, Egnyte and Eric Anthony, Director, MSP Community & Enablement, Egnyte as they kick off the second annual MSP Summit!

Subscribe to